Alterity Therapeutics (ATHE) Revenue (2009 - 2025)

Alterity Therapeutics' Revenue history runs 13 years deep, the most recent figure standing at $5.2 million for Q4 2025.

• In Q4 2025, Revenue rose 37.9% year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $18.2 million (up 1.61% YoY), while the FY2024 annual figure was $18644.0 billion, up 430.01% from the prior year.
• Revenue was $5.2 million for Q4 2025 at Alterity Therapeutics, up from $3.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $4619947000.0 billion in Q2 2024 to a low of $3.8 million in Q4 2024.
• Historically, Revenue has averaged $659992931.1 billion across 5 years, with a median of $5.1 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Revenue sank 99.32% in 2021, then surged 131333910.67% in 2024.
• A 5-year view of Revenue shows it stood at $4.9 million in 2021, then increased by 3.56% to $5.1 million in 2022, then fell by 18.82% to $4.1 million in 2023, then decreased by 8.7% to $3.8 million in 2024, then jumped by 37.9% to $5.2 million in 2025.
• The last three Revenue figures came in at $5.2 million (Q4 2025), $3.8 million (Q4 2024), and $4619947000.0 billion (Q2 2024), per Business Quant data.